Trexquant Investment’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.52M | Buy |
551,430
+101,809
| +23% | +$650K | 0.04% | 663 |
|
2025
Q1 | $2.19M | Sell |
449,621
-251,896
| -36% | -$1.22M | 0.03% | 838 |
|
2024
Q4 | $6.71M | Buy |
701,517
+261,099
| +59% | +$2.5M | 0.08% | 405 |
|
2024
Q3 | $3.68M | Buy |
+440,418
| New | +$3.68M | 0.05% | 594 |
|
2023
Q2 | – | Sell |
-62,698
| Closed | -$650K | – | 1522 |
|
2023
Q1 | $650K | Buy |
+62,698
| New | +$650K | 0.02% | 890 |
|
2022
Q4 | – | Sell |
-30,089
| Closed | -$632K | – | 1449 |
|
2022
Q3 | $632K | Buy |
30,089
+14,412
| +92% | +$303K | 0.02% | 713 |
|
2022
Q2 | $487K | Sell |
15,677
-32,159
| -67% | -$999K | 0.02% | 837 |
|
2022
Q1 | $1.96M | Buy |
+47,836
| New | +$1.96M | 0.09% | 266 |
|
2021
Q4 | – | Sell |
-14,000
| Closed | -$701K | – | 1377 |
|
2021
Q3 | $701K | Buy |
+14,000
| New | +$701K | 0.06% | 413 |
|
2021
Q2 | – | Sell |
-3,942
| Closed | -$366K | – | 1183 |
|
2021
Q1 | $366K | Buy |
+3,942
| New | +$366K | 0.03% | 655 |
|
2020
Q4 | – | Sell |
-17,221
| Closed | -$1.78M | – | 1124 |
|
2020
Q3 | $1.78M | Buy |
+17,221
| New | +$1.78M | 0.11% | 248 |
|
2020
Q2 | – | Sell |
-8,861
| Closed | -$513K | – | 1216 |
|
2020
Q1 | $513K | Buy |
+8,861
| New | +$513K | 0.04% | 648 |
|
2018
Q1 | – | Sell |
-10,635
| Closed | -$494K | – | 1144 |
|
2017
Q4 | $494K | Buy |
+10,635
| New | +$494K | 0.05% | 516 |
|
2017
Q1 | – | Sell |
-6,111
| Closed | -$201K | – | 1135 |
|
2016
Q4 | $201K | Buy |
+6,111
| New | +$201K | 0.03% | 820 |
|
2016
Q2 | – | Sell |
-10,900
| Closed | -$396K | – | 925 |
|
2016
Q1 | $396K | Buy |
+10,900
| New | +$396K | 0.05% | 648 |
|
2015
Q3 | – | Sell |
-8,600
| Closed | -$283K | – | 1084 |
|
2015
Q2 | $283K | Sell |
8,600
-23,600
| -73% | -$777K | 0.03% | 831 |
|
2015
Q1 | $926K | Buy |
+32,200
| New | +$926K | 0.09% | 406 |
|